Clinical trial
Comparison of Two Combination Chemotherapy Regimens in Treating Women With…
NCT00087178 · NSABP Foundation Inc, Other · Completed
Key facts
| NCT number | NCT00087178 |
|---|---|
| Title | Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer |
| Official title | A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer |
| Lead sponsor | NSABP Foundation Inc, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | cyclophosphamide, adriamycin, epirubicin, fluorouracil |
| Enrollment | 2,722 |
| Start date | May 1, 2004 |
| Primary completion | Mar 1, 2014 |
| Completion | May 1, 2016 |
| First posted | Jul 12, 2004 |
| Last update posted | Aug 11, 2022 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: